Mental Disorders
- 4 May 1972
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 286 (18) , 984-987
- https://doi.org/10.1056/nejm197205042861806
Abstract
THE introduction of chlorpromazine and reserpine for treating schizophrenias in 1954 initiated the modern era of psychopharmacology. Not only were these pioneer drugs followed by many others for treating schizophrenic patients, but new types of drugs were soon available for other types of emotional disorders. By 1957, both iproniazid and imipramine had been proposed as treatments for patients with depression. By the mid-1960's, lithium carbonate had finally won acceptance as a treatment for mania. During this entire period, new sedative drugs were developed for treating patients with anxiety. Now we have an abundance of psychotherapeutic drugs, contributing more to the . . .Keywords
This publication has 7 references indexed in Scilit:
- Discontinuation or reduction of chemotherapy in chronic schizophrenicsPublished by Elsevier ,2004
- Comparison of Lithium Carbonate and Chlorpromazine in the Treatment of ManiaArchives of General Psychiatry, 1972
- Lithium in maniaClinical Pharmacology & Therapeutics, 1970
- Studies of delayed‐action medication V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazineClinical Pharmacology & Therapeutics, 1970
- LITHIUM: ELIMINATION RATE, DOSAGE, CONTROL, POISONING, GOITER, MODE OF ACTIONActa Psychiatrica Scandinavica, 1969
- Clinical use of psychotherapeutic drugs: Current statusClinical Pharmacology & Therapeutics, 1969
- Lithium in psychiatric therapy and prophylaxisJournal of Psychiatric Research, 1968